[Arg6]-beta-Amyloid (1-42), English Mutation – 0.5 mg

Overview

[Arg6]-beta-Amyloid (1-42), English Mutation is an essential peptide for researchers studying Alzheimer’s disease. This specific mutation, known as H6A, is recognized for its unique capability to enhance the fibril elongation rate while not increasing protofibril levels. For those investigating neurodegenerative diseases, this peptide serves as a critical tool in the understanding and analysis of beta-amyloid dynamics.

Key Features

• Specifically designed for research in Alzheimer’s disease.
• Accelerates fibril elongation rate.
• Maintains stable protofibril levels.
• Supplied in a 0.5 mg format for convenient research use.
• Supported by extensive scientific research.

Specifications

Product Name	[Arg6]-beta-Amyloid (1-42), English Mutation
Weight	0.5 mg
Category	Peptides

FAQ

What is the significance of the English mutation in beta-amyloid?

The English mutation in beta-amyloid is linked to autosomal dominant Alzheimer’s Disease and is crucial for understanding its pathology.

How does this peptide contribute to Alzheimer’s research?

This peptide aids in studying fibril formation dynamics, providing insights into amyloid aggregation processes relevant to Alzheimer’s.

Is this peptide suitable for in vivo studies?

This product is primarily used for in vitro research. For in vivo studies, please consult our range of protein labeling kits for appropriate applications.

Enhance your research capabilities with [Arg6]-beta-Amyloid (1-42), English Mutation. Buy now and explore its potential in uncovering the complexities of Alzheimer’s disease. You can also check out other valuable products like our PKG Substrate or Autocamtide-2 for further experimentation.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.